Advanced AMD Support

  • Protect Your Macular from Degeneration
  • Better Sight in Sunlight
  • Reduce Dry Eyes
  • Relax Your Eyes

Eyestrain Protect

70% of people working with computers suffer eyestrain. Costing their productivity.

Protect your eyes, your health, and productivity all at once.

Dry Eyes Hydro Guard

Staring at screens for hours per day leaves your eyes dry.

Guard your eyes from itchy and dry eyes. Get Dry Eyes Hydro Guard now!

Study 03: Placebo-Controlled Study Of Zeaxanthin

Optometry. 2011 Nov;82(11):667-680.e6. doi: 10.1016/j.optm.2011.08.008.
Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function
in patients with atrophic age-related macular degeneration


The purpose of this study is to evaluate whether dietary supplementation with the carotenoid zeaxanthin (Zx) raises macula pigment optical density (MPOD) and has unique visual benefits for patients with early atrophic macular degeneration having visual symptoms but lower-risk National Institute of Health/National Eye Institute/Age-Related Eye Disease Study characteristics.

This was a 1-year, n = 60 (57 men, 3 women), 4-visit, intention-to-treat, prospective, randomized controlled clinical trial of patients (74.9 years, standard deviation [SD] 10) with mild-to-moderate age-related macular degeneration (AMD) randomly assigned to 1 of 2 dietary supplement carotenoid pigment intervention groups: 8 mg Zx (n = 25) and 8 mg Zx plus 9 mg lutein (L) (n = 25) or 9 mg L ("Faux Placebo," control group, n = 10). Analysis was by Bartlett's test for equal variance, 3-way repeated factors analysis of variance, independent t test (P < 0.05) for variance and between/within group differences, and post-hoc Scheffé's tests. Estimated foveal heterochromic flicker photometry, 1° macular pigment optical density (MPOD QuantifEye(®)), low- and high-contrast visual acuity, foveal shape discrimination (Retina Foundation of the Southwest), 10° yellow kinetic visual fields (KVF), glare recovery, contrast sensitivity function (CSF), and 6° blue cone ChromaTest(®) color thresholds were obtained serially at 4, 8, and 12 months.

Ninety percent of subjects completed ≥ 2 visits with an initial Age-Related Eye Disease Study report #18 retinopathy score of 1.4 (1.0 SD)/4.0 and pill intake compliance of 96% with no adverse effects. There were no intergroup differences in 3 major AMD risk factors: age, smoking, and body mass index as well as disease duration and Visual Function Questionnaire 25 composite score differences. Randomization resulted in equal MPOD variance and MPOD increasing in each of the 3 groups from 0.33 density units (du) (0.17 SD) baseline to 0.51 du (0.18 SD) at 12 m, (P = 0.03), but no between-group differences (Analysis of Variance; P = 0.47). In the Zx group, detailed high-contrast visual acuity improved by 1.5 lines, Retina Foundation of the Southwest shape discrimination sharpened from 0.97 to 0.57 (P = 0.06, 1-tail), and a larger percentage of Zx patients experienced clearing of their KVF central scotomas (P = 0.057). The "Faux Placebo" L group was superior in terms of low-contrast visual acuity, CSF, and glare recovery, whereas Zx showed a trend toward significance.

In older male patients with AMD, Zx-induced foveal MPOD elevation mirrored that of L and provided complementary distinct visual benefits by improving foveal cone-based visual parameters, whereas L enhanced those parameters associated with gross detailed rod-based vision, with considerable overlap between the 2 carotenoids. The equally dosed (atypical dietary ratio) Zx plus L group fared worse in terms of raising MPOD, presumably because of duodenal, hepatic-lipoprotein or retinal carotenoid competition. These results make biological sense based on retinal distribution and Zx foveal predominance.
Published by Elsevier Inc.

Featured Products

Advanced AMD Support


Powerful support for your macular to protect from degeneration. Promotes better sight in sunlight.*

Dry Eyes Hydro


Powerful support for your macular to protect from degeneration. Promotes better sight in sunlight.*

Eyestrain Protect


Powerful support for your macular to protect from degeneration. Promotes better sight in sunlight.*

Products Based on Science

Check the studies that back our claims, ingredients and formulation. Open and transparent. 

Study 01 - Lutein & Zeaxanthin

Lutein and zeaxanthin in the eyes, serum and diet of human subjects.

Study 04: Measurement Of Ocular Blood Flow

Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration

Study 02: A One Year Study of the Macular Pigment

A One Year Study of the Macular Pigment: The Effect of 140 Days of a Lutein Supplement.

Study 05: Macular Carotenoid Supplementation

Macular carotenoid supplementation in
subjects with atypical spatial profiles
of macular pigment.

Study 03: Placebo-Controlled Study Of Zeaxanthin

Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function...

Study 06: Supplementation With 3 Macular Carotenoids

Supplementation with all three
macular carotenoids: response,
stability, and safety.

About Us:

EyesightLabs™ provides premium nutritional supplements for your eyesight and health. We believe that supplements should benefit your health without negative side-effects. Learn more about the science that supports our formulas.

Search For Products:

Contact Us:

2885 Stanford Ave #10001
Grandville, MI 49418

(844) 230.63.83

*These statements have not been evaluated by the Food & Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
The information on the website doesn't constitute a doctor-patient relationship. It for educational purposes only. Be sure to consult your duly licensed
physician before taking any supplements. Consult your doctor regarding any interactions with your health problems.